Health status, hospitalizations, day procedures, and physician costs associated with body mass index (BMI) levels in Ontario, Canada
Jean-Eric Tarride1,2, Mahbubul Haq1, Valerie H Taylor3, Arya M Sharma4, Hamid Reza Nakhai-Pour1, Daria O’Reilly1,2, Feng Xie1,2, Lisa Dolovich2,5,6, Ron Goeree1,2
1Programs for Assessment of Technology in Health (PATH) Research Institute, St Joseph’s Healthcare Hamilton, Hamilton, Ontario, Canada; 2Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada; 3Department of Psychiatry, University of Toronto, Ontario, Canada; 4Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; 5Centre for Evaluation of Medicines, St Joseph’s Healthcare Hamilton, Hamilton, Ontario, Canada; 6Department of Family Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada
Background: Obesity is today’s principal neglected public health problem, as a rising proportion of adults will succumb to the medical complications of obesity. However, little is known about the burden of obesity in adults living in Ontario.
Objectives: To present an overview of the human and economic burden associated with BMI categories in Ontario, Canada, in terms of socio-demographics, comorbidities, health-related quality of life (HRQoL) and costs associated with hospitalization, same day procedures and physician visits.
Methods: The records of all Ontarians who participated in the Canadian Community Health Survey (CCHS), cycle 1.1 and provided consent to data linkage were linked to three administrative databases. Socio-demographic variables, medical characteristics, HRQoL, one year hospitalization, day procedure and physician costs were described per BMI category. Regression analyses were conducted to identify predictors of medical characteristics, HRQoL and costs.
Results: More than 50% of adult participants were either overweight or obese in 2000/2001. Obese adults, and to a lesser extent overweight adults, were more likely to report physician-diagnosed comorbid conditions, to use medications, and to have a lower HRQoL. After covariate adjustment, the hospitalization and physician costs were respectively 40% and 22% higher among obese and overweight adults than among normal-weight adults. No statistical cost differences were observed between normal and underweight individuals or between normal and overweight individuals. HRQoL was significantly lower in underweight and obese adults when compared to normal-weight individuals.
Conclusions: Due to the large human and economic burden associated with under- or excess-weight, policies promoting healthy weight should remain a priority for governments and employers.
Keywords: health-related quality of life, costs, body mass index categories, Ontario
This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php
Other article by this author:
Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents
Tarride JE, Burke N, Von Keyserlingk C, O'Reilly D, Xie F, Goeree R
Published Date: 4 October 2012
Readers of this article also read:
Eldo E Frezza, Mitchell Wacthell, Bradley Ewing
Published Date: 10 December 2009
Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients
Luca Degli Esposti, Stefania Saragoni, Silvia Benemei, et al
Published Date: 7 March 2011
Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application
Goeree R, He J, O'Reilly D, Tarride J-E, Xie F, Lim M, Burke N
Published Date: 2 June 2011
Cross-market cost-effectiveness analysis of erlotinib as first-line maintenance treatment for patients with stable non-small cell lung cancer
Vergnenègre A, Ray JA, Chouaid C, Grossi F, Bischoff HG, Heigener DF, Walzer S
Published Date: 26 January 2012
Forecast model for the evaluation of economic resources employed in the health care of patients with HIV infection
Sacchi P, Patruno SFA, Bruno R, Cima SMB, Previtali P, Franchini A, Nicolini L, Rognoni C, Sacchi L, Bellazzi R, Filice G
Published Date: 11 May 2012
Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: a post hoc cost-effectiveness analysis in usual medical practice in Spain
De Salas-Cansado M, Olivares JM, Álvarez E, Carrasco JL, Barrueta A, Rejas J
Published Date: 13 June 2012
Cost comparison of second-line treatment options for late stage non-small-cell lung cancer: cost analysis for Italy
Schwander B, Ravera S, Giuliani G, Nuijten M, Walzer S
Published Date: 3 September 2012
Co-nanoencapsulation of magnetic nanoparticles and selol for breast tumor treatment: in vitro evaluation of cytotoxicity and magnetohyperthermia efficacy
Estevanato LC, Da Silva JR, Falqueiro AM, Mosiniewicz-Szablewska E, Suchocki P, Tedesco AC, Morais PC, Lacava ZG
Published Date: 5 October 2012
Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?
Thavorncharoensap M, Teerawattananon Y, Natanant S, Kulpeng W, Yothasamut J, Werayingyong P
Published Date: 10 January 2013
Sexual behaviors among men who have sex with men: a quantitative cross sectional study in Kathmandu Valley, Nepal
Mishra SR, Khanal V
Published Date: 15 April 2013